Targeting circadian transcriptional programs in triple negative breast cancer through a cis-regulatory mechanism
Yuanzhong Pan, Tsu-Pei Chiu, Lili Zhou…·Steve A. Kay
This paper identifies a cis-regulatory mechanism in triple-negative breast cancer where targeting circadian transcription factors with small molecules represses a circadian transcriptional program, offering a new therapeutic strategy.